Drosophila Melanogaster Deoxyribonucleoside Kinase Activates Gemcitabine.
Knecht, W., Mikkelsen, N.E., Clausen, A., Willer, M., Eklund, H., Gojkovic, Z., Piskur, J.(2009) Biochem Biophys Res Commun 382: 430
- PubMed: 19285960 
- DOI: https://doi.org/10.1016/j.bbrc.2009.03.041
- Primary Citation of Related Structures:  
2VPP - PubMed Abstract: 
Drosophila melanogaster multisubstrate deoxyribonucleoside kinase (Dm-dNK) can additionally sensitize human cancer cell lines towards the anti-cancer drug gemcitabine. We show that this property is based on the Dm-dNK ability to efficiently phosphorylate gemcitabine. The 2.2A resolution structure of Dm-dNK in complex with gemcitabine shows that the residues Tyr70 and Arg105 play a crucial role in the firm positioning of gemcitabine by extra interactions made by the fluoride atoms. This explains why gemcitabine is a good substrate for Dm-dNK.
Organizational Affiliation: 
BioCentrum-DTU, Technical University of Denmark, Lyngby, Denmark.